If you have any problems in viewing this Newsletter, please click here
Targeting EGFR in Lung Cancer
EGFR mutations occur within exons 18-21 encoding a portion of the EGFR kinase domain. These mutations affect the kinase activity of EGFR, leading to downstream pro-survival signaling pathways. More
mutaFISH™ EGFR T790M T790wt RNA Probes CHF
mutaFISH™ EGFR L858R L858wt Ex19wt RNA Probes CHF
EGFR (T790M) (Human) Recombinant ProteinBioActive CHF
EGFR (L858R) (Human) Recombinant Protein BIOACTIVE CHF
EGFR & ERBB2 Protein Protein Interaction Antibody Pair CHF
EGFR/ERBB2 (phospho Y1173/Y1248) polyclonal antibody CHF
EGFR recombinant monoclonal antibody, clone C225 (Cetuximab) CHF
Phosphotyrosine EGFR (Human) ELISA Kit CHF
EGFR (Human) Cell-Based ELISA Kit CHF
Cancer-Associated IDH1/2 Mutations
IDH1 and IDH2 mutations have been identified in >80% of low-grade gliomas and secondary glioblastomas, 60% of chondroblastomas, 20% of intrahepatic cholangio-carcinomas as well as in 10% of acute myeloyd leukemia.
mutaFISH™ IDH1 R132H R132wt IDH2 R172K R172wt RNA Probes CHF
IDH2 Pre-design Chimera RNAi CHF
IDH1 monoclonal antibody, clone IDH1/1152 CHF
IDH2 monoclonal antibody (M01), clone 5F11 CHF
IDH1 purified MaxPab rabbit polyclonal antibody (D01P) CHF
IDH2 MaxPab rabbit polyclonal antibody (D01) CHF
IDH2 (Human) IP-WB Antibody Pair CHF
IDH1 (Human) Recombinant Protein (P01) CHF
Email: lucerna-chem@lucerna-chem.ch Phone: +41 41 420 96 36 Fax: +41 41 420 96 56 Web: www.lucerna-chem.ch
 Lucerna-Chem,  AG Abendweg 18,  CH-6006 Luzern

Lucerna-Chem respects the web and the privacy of those who use it. We do not rent or sell our mailing list to anyone.
This e-Mail is Virus checked!

If you'd rather not receive Emails about product updates or Newsletters, click HERE.